Roivant Sciences Ltd.
ROIV
$11.40
$0.3152.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.89B | 5.15B | 5.39B | 5.68B | 6.49B |
| Total Receivables | -- | 143.78M | 22.68M | 215.22M | -- |
| Inventory | -- | -- | -- | 34.00M | -- |
| Prepaid Expenses | -- | 57.66M | 54.84M | 57.28M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 113.17M | 16.02M | 336.94M | 16.49M | 236.88M |
| Total Current Assets | 5.00B | 5.36B | 5.80B | 6.00B | 6.73B |
|
|
|||||
| Total Current Assets | 5.00B | 5.36B | 5.80B | 6.00B | 6.73B |
| Net Property, Plant & Equipment | 101.08M | 104.46M | 56.65M | 63.15M | 59.32M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 136.01M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 32.86M | 33.88M | 36.90M | 32.81M | 183.58M |
| Total Assets | 5.44B | 5.79B | 6.21B | 6.50B | 7.22B |
|
|
|||||
| Total Accounts Payable | 23.69M | 23.71M | 25.13M | 27.74M | 14.03M |
| Total Accrued Expenses | 114.29M | 104.32M | 111.47M | 138.29M | 119.42M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.84M | 9.84M | 9.52M | 21.49M | 8.97M |
| Total Finance Division Other Current Liabilities | 1.58M | 3.61M | 410.13M | 27.53M | 124.35M |
| Total Other Current Liabilities | 1.58M | 3.61M | 410.13M | 27.53M | 124.35M |
| Total Current Liabilities | 149.41M | 141.48M | 556.25M | 215.05M | 266.76M |
|
|
|||||
| Total Current Liabilities | 149.41M | 141.48M | 556.25M | 215.05M | 266.76M |
| Long-Term Debt | -- | -- | -- | 311.72M | 430.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 90.33M | 90.48M | 43.19M | 45.85M | 45.02M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.00M | 24.41M | 26.55M | 28.55M | 462.18M |
| Total Liabilities | 249.74M | 256.38M | 625.99M | 601.16M | 773.95M |
|
|
|||||
| Common Stock & APIC | 4.56B | 4.72B | 4.78B | 4.78B | 5.40B |
| Retained Earnings | 116.06M | 460.40M | 395.58M | 671.47M | 576.17M |
| Treasury Stock & Other | 9.44M | 8.06M | -18.04M | -17.95M | -4.08M |
| Total Common Equity | 4.69B | 5.19B | 5.15B | 5.44B | 5.97B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.69B | 5.19B | 5.15B | 5.44B | 5.97B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 499.59M | 346.50M | 427.09M | 459.98M | 479.95M |
| Total Equity | 5.19B | 5.54B | 5.58B | 5.90B | 6.45B |
|
|
|||||